Rocket Biotechs

Description:

As of late, the biotech sector has seen some serious momentum. Take Pfizer (PFE), which just bought Wyeth (WYE) for $65 billion dollars, or Bristol-Myers Squibb (BMY) publicly said that they are looking to invest $8 billion dollars or so into the biotech space going forward.
Over the last 3 months, shares of biotechnology firms Geron (GERN) and StemCells (STEM) are up roughly 200%, which compares to a decline in the Standard & Poor’s 500 Index (SPY) of almost 5% and a decline in the NASDAQ Biotechnology ETF (^NBI) of about 3%

Most Viewed Portfolios

View All

Articles

7 Stocks Soaring on Big Volume

05.31.12 | 01:15 PM

WINDERMERE, Fla. (Stockpickr) -- Professional traders running mutual funds and hedge funds don’t just look at a stock’s price moves; they also ...

5 Blue-Chip Stocks to Avoid

05.31.12 | 12:28 PM

 BALTIMORE (Stockpickr) -- Yesterday was a nasty little reminder that Europe is still grabbing headlines, whether investors like it or not. T...

More Articles
blog comments powered by Disqus
Get started with stockpickr! Get recommendations from thousands of mutual funds, hedge funds, and others. Enter your favorite stocks now!
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter